Jury Returns Verdict for Bayer in Nation's First Baycol Trial
March 18, 2003
CORPUS CHRISTI, Texas - Following three days of deliberation, the jury in the nation's first Baycol products liability trial has found in favor of manufacturer Bayer Corp. in a suit filed by a man who allegedly developed rhabdomyolysis as a result of using the cholesterol-lowering drug. Hollis Haltom v. Bayer Corporation, No. 02-60165-4 (Texas Dist. Ct., Nueces Cty.).
The Nueces County District Court jury said in its March 18 verdict that the drug company acted responsibly in marketing, developing and voluntarily withdrawing the drug and rejected claims that the manufacturer should pay $560 million in damages to 82-year-old Hollis Haltom …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach